Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We report a detailed analysis of the distribution of relevant proteins of the endogenous cannabinoid system in the rat cerebellum (cerebellar cortex and deep cerebellar nuclei) and the two functionally related nuclei, the vestibular nuclei and the inferior olive. These proteins include the two main cannabinoid receptors (CB 1 and CB 2), the enzymes involved in cannabinoid biosynthesis (DAGLα, DAGLβ, and NAPE‐PLD), and the endocannabinoid‐degradating enzymes (FAAH and MAGL). With regard to the cerebellar cortex, these data confirm several published reports on the distribution of cannabinoid CB 1 receptors, DAGLα, MAGL, and FAAH, which suggests a role of endocannabinoids as retrograde messengers in the synapses of the Purkinje cells by either parallel fibers of granule cells or climbing fibers from the inferior olive or GABAergic interneuron. Additionally, we describe the presence of CB 2 receptors in fibers related to Purkinje somata (Pinceau formations) and dendrites (parallel fibers), suggesting a potential role of this receptor in the retrograde cannabinoid signaling. A remarkable finding of the present study is the description of the different elements of the endogenous cannabinoid system in both the main afferent nuclei to the cerebellar cortex (the inferior olive) and the efferent cerebellar pathway (the deep cerebellar nuclei). The presence of the endogenous cannabinoid system at this level establishes the basis for endocannabinoid‐mediated synaptic plasticity as a control mechanism in motor learning, opening new research lines for the study of the contribution of this system in gait disorders affecting the cerebellum. J. Comp. Neurol. 509:400–421, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“1B; Mechoulam et al., 1995; Sugiura et al., 1995; Piomelli et al., 2000; Bisogno et al., 2003).”
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 3×
“…dense [3H]CP-55,940 labelling in the molecular layer and sparse binding in the granular layer, including mutant mice deficient in Purkinje cell expression, suggesting that Purkinje cells were not the source of CB1 expression in the molecular layer (Herkenham et al., 1991a,b; Herkenham, 1995).”
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · cited 1×
“There are some studies demonstrating the presence of the cannabinoid degradation enzymes FAAH (Cravatt et al., 1995, 1996; Egertová et al., 1998; Goparaju et al., 1998; Tsou et al., 1998) and MAGL (Dihn et al., 2002) in the brain.”
Self-citationEndogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · cited 1×
“…areas, including cerebellum, amygdala, basal ganglia, and hippocampus (Stella et al., 1997; Rodrı́guez de Fonseca et al., 1998, 2005; Giufrida et al., 1999; Wilson and Nicoll, 2001; Wilson et al., 2001; Diana et al., 2002; Gerdeman et al., 2002; Robbe et al., 2002; Chevaleyre and Castillo, 2003).”
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · cited 3×
“In addition, CB1 receptors are located in axon terminals of cerebellar basket and stellate cells providing inhibitory input on Purkinje cells (Mailleux and Vanderhaeghen, 1992; Matsuda et al., 1993; Tsou et al., 1998; Egertová and Elphick, 2000; Cristino et al., 2006; Kawamura et al., 2006).”
Self-citationA second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Self-citationBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Self-citationA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 3×
“1B; Piomelli et al., 2000; Blankman et al., 2007).”
Self-citationGlass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · cited 1×
“…binding and the low intensity of CB1 mRNA signal found in the deep cerebellar nuclei, vestibular nuclei, and IO (Herkenham et al., 1991b; Matsuda et al., 1993) but also with the low levels of CB1 radiographic labelling in the human medial and lateral vestibular nucleus (Glass et al., 1997).”
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · cited 12×
“Similarly to DAGL and DAGL , the postsynaptic localization of NAPE-PLD in Purkinje somata and granular somata correlates with the presynaptic localization of CB1 and CB2 receptor in clustered basket cell axons (Pinceau formation) and the location of CB2 receptor in mossy fibers, whereas the postsynaptic localization o…”
InfluentialCannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
An endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · cited 1×
“The findings of Mucciolli and collaborators suggest that the cloned MAGL, which is responsible for the majority of 2-AG hydrolysis in healthy brains (Hohmann et al., 2005), does not play a major role in primary microglia.”
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 6×
“In addition, CB1 receptors are located in axon terminals of cerebellar basket and stellate cells providing inhibitory input on Purkinje cells (Mailleux and Vanderhaeghen, 1992; Matsuda et al., 1993; Tsou et al., 1998; Egertová and Elphick, 2000; Cristino et al., 2006; Kawamura et al., 2006).”
InfluentialChemical characterization of a family of brain lipids that induce sleep
Cravatt, B. F., Prospero-Garcia, O., Siuzdak, G., Gilula, N. B., Henriksen, S. J., Boger, D. L., & Lerner, R. A. (1995) · Science · doi:10.1126/science.7770779 · Cited by 620 · cited 1×
“There are some studies demonstrating the presence of the cannabinoid degradation enzymes FAAH (Cravatt et al., 1995, 1996; Egertová et al., 1998; Goparaju et al., 1998; Tsou et al., 1998) and MAGL (Dihn et al., 2002) in the brain.”
Self-citationGulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561 · cited 6×
“Consistent with previous studies of the rodent and human cerebellar cortex (Egertová et al., 1998, 2003; Romero et al., 2002; Gulyas et al., 2004), FAAH immunoreactivity was present in Purkinje somata.”
InfluentialSelf-citationThe endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421 · cited 3×
“1B; Piomelli et al., 2000; Blankman et al., 2007).”
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · cited 1×
“However, so far, little information is available on the presence and function of the cannabinoid CB2 receptor (Skaper et al., 1996; Lu et al., 2000; Zhang et al., 2003; Pazos et al., 2004; Benito et al., 2005; Sheng et al., 2005) and other components of the endocannabinoid system, such as…”
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347 · cited 6×
“Consistent with previous studies of the rodent and human cerebellar cortex (Egertová et al., 1998, 2003; Romero et al., 2002; Gulyas et al., 2004), FAAH immunoreactivity was present in Purkinje somata.”
InfluentialSelf-citationValenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · cited 1×
“The effects on ataxia are mediated by cannabinoid CB1 receptors, and apparently there are no CB2-mediated gait alterations in experimental animals (Patel and Hillard, 2001; Valenzano et al., 2005).”
Cited by
An Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234
“Cerebellar CB1 receptors are found in parallel and climbing fibers, as well as in basket cells (20, 21).”
BackgroundSelf-citationThe CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.021 · Cited by 472
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S.-J., & Mackie, K. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 174
“Cerebellar and functionally related vestibular nuclei have numerous MAGLimmunoreactive neurons, showing a perikaryal and dendritic Golgi-like labeling, similar to that of DAGLβ (Suarez et al. 2008).”
BackgroundResultInfluentialSelf-citationWilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.038 · Cited by 79
“Previous studies have demonstrated that the rabbit anti-CB1 receptor antibody recognizes its antigen in rat cerebellum tissue using Western blotting (Suarez et al., 2008) and that CB1 receptor labeling is absent in cerebellar and hippocampal tissue from CB1 receptor knockout mice (Suarez et al.”
Background
Metadata
- Authors
- Suárez, J., Bermúdez‐Silva, F. J., Mackie, K., Ledent, C., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2008-06-02
- Volume
- 509
- Issue
- 4
- Pages
- 400-421
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2084821051
- Cited by
- 126
- References
- 22
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.